| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | Infusion |
|
Still deciding? Get samples of US$ 0.2/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Specifaction: Solution for infusion, 100ml PP bottle
Description: Clear, colourless or slightly yellow solution.
Ingredient: Ciprofloxacin 2mg/ml; Sodium Chloride 9mg/ml
INDICATIONS: Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated.
1.1 Skin and Skin structure Infections
1.2 Bone and Joint infections
1.3 Complicated Intra-Abdominal infections
1.4 Nosocomial Pneumonia
1.5 Empirical Therapy for Febrile Neutropenic Patients
1.6 Inhalational Anthrax Post-Exposure in Adult and Pediatric Patients
1.7 Plague in adult and pediatric patients
1.8 Chronic Bacterial Prostatitis
1.9 Lower respiratory tract infections
1.10 Acute Exacerbation of Chronic Bronchitis
1.11 Urinary Tract Infections
1.12 Urinary Tract Infections
1.13 Complicated UTI and Pyelonephritis in Pediatric Patients
1.14 Acute Sinusitis
Manufacturer: Shijiazhuang No.4 Pharmaceutical Co.,Ltd.
Scale: there are 8 workshops, including 5 large volume infusion workshops, two oral preparation workshops and an ampoule workshop. There are 10 dosage forms: large volume injection, irrigation, tablet, capsule, granules, suspension, oral liquid, mixture, and small volume injection, with 156 different products.
Specialty: Our leading product is large volume injection, including PP Bottles, Nom-PVC co-extrusion multiplayer infusion bags, Glass bottles,pack size are 2000ml,1000ml,500ml,250ml,100ml,50ml,the current output is more than 1.2 billion bottles or bags annually.
QRM Principle: to promote quality improvement, to reduce drug risk, to ensure patient safety. By means of risk management of pharmaceutical manufacturing process, the product quality risk can be minimized to ensure the quality of products.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.
The products have been sold to some countries and regions in South America, Africa, and Asia.
){kind=link}